Video

Dr. Kelly Stratton discusses 2022 SUO Kidney Cancer Course

Author(s):

Urology Times staff
Conference|SUO Annual Meeting

“It's very interesting to see how this continues to progress as a field,” says Kelly L. Stratton, MD FACS.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Kelly L. Stratton, MD, FACS, discusses the Kidney Cancer Course held during the 2022 Society of Urologic Oncology Annual Meeting. Stratton is an assistant professor of urologic oncology at the University of Oklahoma, Oklahoma City.

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      Subscribe Now!
      Related Videos
      Jad Chahoud, MD, on the phase 1b STELLAR-002 trial in ccRCC
      Jad Chahoud, MD, on the phase 1b STELLAR-002 trial in ccRCC
      Jens Bedke, MD, on efficacy of EV plus pembrolizumab across subgroups in la/mUC
      Jens Bedke, MD, on efficacy of EV plus pembrolizumab across subgroups in la/mUC
      Professor Dickon Hayne shares data on mitomycin plus BCG in high-risk NMIBC
      Professor Dickon Hayne shares data on mitomycin plus BCG in high-risk NMIBC
      Related Content
      Diverse doctors having an emergency discussion | Image Credit: © Flamingo Images - stock.adobe.com
      September 23rd 2025

      Navigating the urology workforce crisis: A call to action

      Michael S. Cookson, MD, MMHC, FACS
      Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
      September 23rd 2025

      Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25

      Amy M. Pearlman, MD Kevin C. Zorn, MD, FRCSC, FACS
      Conceptual image for viral ethiology of prostate cancer. 3D illustration showing Human Papilloma Viruses HPV infecting prostate gland which develops cancerous tumor | Image Credit: © Dr_Microbe - stock.adobe.com
      September 23rd 2025

      Biden’s prostate cancer diagnosis underscores importance of screening, awareness

      Hannah Clarke
      Pearls & Perspectives: Future of reconstructive urology, with Ryan Terlecki, MD, at AUA 2025
      September 23rd 2025

      Pearls & Perspectives: Future of reconstructive urology, with Ryan Terlecki, MD, at AUA 2025

      Amy M. Pearlman, MD Ryan Terlecki, MD
      Prostate cancer awareness in 2025: A human imperative in the wake of President Biden’s diagnosis
      September 23rd 2025

      Prostate cancer awareness in 2025: A human imperative in the wake of President Biden’s diagnosis

      Michael S. Cookson, MD, MMHC, FACS
      Study finds racial/ethnic disparities in use of PSMA-PET in prostate cancer
      September 23rd 2025

      Study finds racial/ethnic disparities in use of PSMA-PET in prostate cancer

      Hannah Clarke
      © 2025 MJH Life Sciences

      All rights reserved.